D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 93 Citations 27,318 322 World Ranking 5214 National Ranking 2928

Research.com Recognitions

Awards & Achievements

2017 - Member of the National Academy of Medicine (NAM)

1951 - Fellow of the American Association for the Advancement of Science (AAAS)

Member of the Association of American Physicians

Overview

What is he best known for?

The fields of study he is best known for:

  • Cancer
  • Internal medicine
  • Surgery

John H. Sampson mainly investigates Internal medicine, Glioma, Immunology, Surgery and Oncology. As a part of the same scientific study, John H. Sampson usually deals with the Internal medicine, concentrating on Gastroenterology and frequently concerns with Regimen and Survival rate. His study in Glioma is interdisciplinary in nature, drawing from both Bone marrow, Pathology, Magnetic resonance imaging, Drug delivery to the brain and Volume of distribution.

The study of Immunology is intertwined with the study of Epidermal growth factor receptor in a number of ways. He interconnects Adverse effect and Urology in the investigation of issues within Surgery. His Oncology study integrates concerns from other disciplines, such as Cancer, Recurrent glioblastoma and Pharmacology.

His most cited work include:

  • Bevacizumab Plus Irinotecan in Recurrent Glioblastoma Multiforme (1184 citations)
  • Phase II Trial of Gefitinib in Recurrent Glioblastoma (650 citations)
  • Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor Variant III Peptide Vaccination in Patients With Newly Diagnosed Glioblastoma (587 citations)

What are the main themes of his work throughout his whole career to date?

John H. Sampson mainly focuses on Immunology, Immunotherapy, Internal medicine, Cancer research and Glioma. He has included themes like Cancer and Epidermal growth factor receptor in his Immunology study. His Immunotherapy study combines topics in areas such as Brain tumor, Dendritic cell, Clinical trial and Adoptive cell transfer.

His Internal medicine study combines topics from a wide range of disciplines, such as Surgery and Oncology. His Cancer research research is multidisciplinary, incorporating perspectives in T cell, Cytotoxic T cell, Immunotoxin and Pathology. His study on Glioma is mostly dedicated to connecting different topics, such as Toxicity.

He most often published in these fields:

  • Immunology (27.45%)
  • Immunotherapy (25.85%)
  • Internal medicine (25.25%)

What were the highlights of his more recent work (between 2017-2021)?

  • Cancer research (24.25%)
  • Immunotherapy (25.85%)
  • Internal medicine (25.25%)

In recent papers he was focusing on the following fields of study:

Cancer research, Immunotherapy, Internal medicine, Oncology and Glioma are his primary areas of study. John H. Sampson has researched Cancer research in several fields, including T cell, Cancer, Interleukin-4 receptor and CD3. Immunotherapy is a subfield of Immune system that John H. Sampson explores.

The subject of his Immune system research is within the realm of Immunology. The Oncology study combines topics in areas such as Survival rate and Chemotherapy, Temozolomide. His work carried out in the field of Glioma brings together such families of science as Rhinovirus, Immunotoxin, Antibody and Toxicity.

Between 2017 and 2021, his most popular works were:

  • Recurrent glioblastoma treated with recombinant poliovirus (243 citations)
  • Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors. (162 citations)
  • Challenges to curing primary brain tumours (159 citations)

In his most recent research, the most cited papers focused on:

  • Cancer
  • Internal medicine
  • Surgery

John H. Sampson mostly deals with Immunotherapy, Cancer research, Internal medicine, Oncology and Immune system. His biological study spans a wide range of topics, including Tumor microenvironment, Immunosuppression and Oncolytic virus. His research integrates issues of Cancer cell, Cancer, Reprogramming, T cell and Stem cell in his study of Cancer research.

His study in Clinical trial, Randomized controlled trial and Regimen falls within the category of Internal medicine. His studies in Oncology integrate themes in fields like Survival rate and Glioblastoma, Glioma, Temozolomide. John H. Sampson combines subjects such as Combined Modality Therapy, Antibody titer, Germinal center and Bioinformatics with his study of Immune system.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Bevacizumab Plus Irinotecan in Recurrent Glioblastoma Multiforme

James J. Vredenburgh;Annick Desjardins;James E. Herndon;Jennifer Marcello.
Journal of Clinical Oncology (2007)

1562 Citations

Phase II Trial of Gefitinib in Recurrent Glioblastoma

Jeremy N. Rich;David A. Reardon;Terry Peery;Jeannette M. Dowell.
Journal of Clinical Oncology (2004)

809 Citations

Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor Variant III Peptide Vaccination in Patients With Newly Diagnosed Glioblastoma

John H. Sampson;Amy B Heimberger;Gary E. Archer;Kenneth D. Aldape.
Journal of Clinical Oncology (2010)

731 Citations

Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma

John H. Sampson;James H. Carter;Allan H. Friedman;Hilliard F. Seigler.
Journal of Neurosurgery (1998)

580 Citations

Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant glioma.

Peter E. Fecci;Duane A. Mitchell;John F. Whitesides;Weihua Xie.
Cancer Research (2006)

507 Citations

Proteomic and immunologic analyses of brain tumor exosomes

Michael W. Graner;Oscar Alzate;Angelika M. Dechkovskaia;Jack D. Keene.
The FASEB Journal (2009)

406 Citations

Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma.

Sandeep Kunwar;Susan Chang;Manfred Westphal;Michael Vogelbaum.
Neuro-oncology (2010)

394 Citations

Immunotherapy response assessment in neuro-oncology: a report of the RANO working group.

Hideho Okada;Michael Weller;Raymond Huang;Gaetano Finocchiaro.
Lancet Oncology (2015)

391 Citations

Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma

Duane A. Mitchell;Weihua Xie;Robert Schmittling;Chris Learn.
Neuro-oncology (2008)

385 Citations

Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients

Duane A. Mitchell;Kristen A. Batich;Michael D. Gunn;Min-Nung Huang.
Nature (2015)

375 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing John H. Sampson

Patrick Y. Wen

Patrick Y. Wen

Harvard University

Publications: 168

David A. Reardon

David A. Reardon

Harvard University

Publications: 139

Michael Weller

Michael Weller

University of Zurich

Publications: 129

Wolfgang Wick

Wolfgang Wick

German Cancer Research Center

Publications: 111

Darell D. Bigner

Darell D. Bigner

Duke University

Publications: 81

Timothy F. Cloughesy

Timothy F. Cloughesy

University of California, Los Angeles

Publications: 79

Mark R. Gilbert

Mark R. Gilbert

The University of Texas MD Anderson Cancer Center

Publications: 77

Hideho Okada

Hideho Okada

University of California, San Francisco

Publications: 70

Pedro R. Lowenstein

Pedro R. Lowenstein

University of Michigan–Ann Arbor

Publications: 66

Roger Stupp

Roger Stupp

Northwestern University

Publications: 66

Maria G. Castro

Maria G. Castro

University of Michigan–Ann Arbor

Publications: 65

Susan M. Chang

Susan M. Chang

University of California, San Francisco

Publications: 59

Henry S. Friedman

Henry S. Friedman

Duke University

Publications: 56

Alba A. Brandes

Alba A. Brandes

Institute of Neurological Sciences

Publications: 56

E. Antonio Chiocca

E. Antonio Chiocca

Brigham and Women's Hospital

Publications: 56

Michael A. Vogelbaum

Michael A. Vogelbaum

Cleveland Clinic

Publications: 56

Something went wrong. Please try again later.